Orthopedic Applications
Osteoarthritis, Degenerative Spine Disease, Shoulder Impingement, Meniscus Tears
Commercial/ResearchActive
Key Facts
Indication
Osteoarthritis, Degenerative Spine Disease, Shoulder Impingement, Meniscus Tears
Phase
Commercial/Research
Status
Active
Company
About Orthogen
Orthogen AG is a pioneering German biotech firm with over 25 years of experience in molecular and autologous medicine. It has developed proprietary platform technologies that harness the body's own immune mediators to address the root causes of diseases, moving beyond symptom management. The company's applications span orthopedics, pain management, veterinary medicine, aesthetics, and several autoimmune and chronic conditions, with over 400,000 treatments administered globally. Led by its founder and CEO, Dr. Peter Wehling, Orthogen operates as a private, research-driven entity aiming to shift treatment paradigms in regenerative medicine.
View full company profile